Amyloid Beta (A4) Precursor Protein: A Potential Biomarker for Recurrent Nasopharyngeal Carcinoma

BACKGROUND AND AIM: Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Southern China, Southeast Asia. Radiotherapy is the main treatment for NPC. Still, about 20% of patients with NPC have a recurrence. No effective serum biomarkers are available for recurrent nasopharyngeal carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Yu, Meng, Hui-Ling, Li, Kai-Guo, Yang, Xiao-Hui, Zhu, Xiao-Dong, Li, Ling, Liang, Zhong-Guo, Pan, Xin-Bin, Zeng, Fan-Yan, Qu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929967/
https://www.ncbi.nlm.nih.gov/pubmed/31908537
http://dx.doi.org/10.2147/CMAR.S218030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929967/
https://www.ncbi.nlm.nih.gov/pubmed/31908537
http://dx.doi.org/10.2147/CMAR.S218030

Ejemplares similares